CN112645998B - Method for synthesizing tauroursodeoxycholic acid under catalysis of borate - Google Patents
Method for synthesizing tauroursodeoxycholic acid under catalysis of borate Download PDFInfo
- Publication number
- CN112645998B CN112645998B CN202011531308.0A CN202011531308A CN112645998B CN 112645998 B CN112645998 B CN 112645998B CN 202011531308 A CN202011531308 A CN 202011531308A CN 112645998 B CN112645998 B CN 112645998B
- Authority
- CN
- China
- Prior art keywords
- tauroursodeoxycholic
- acid
- acid ester
- synthesizing
- boric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- BHTRKEVKTKCXOH-UHFFFAOYSA-N Taurochenodesoxycholsaeure Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)CC2 BHTRKEVKTKCXOH-UHFFFAOYSA-N 0.000 title claims abstract description 72
- BHTRKEVKTKCXOH-LBSADWJPSA-N tauroursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)CC1 BHTRKEVKTKCXOH-LBSADWJPSA-N 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000006555 catalytic reaction Methods 0.000 title claims abstract description 17
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 14
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 title abstract description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 40
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 claims abstract description 31
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229960001661 ursodiol Drugs 0.000 claims abstract description 30
- -1 boric acid ester Chemical class 0.000 claims abstract description 26
- 239000004327 boric acid Substances 0.000 claims abstract description 25
- 229960003080 taurine Drugs 0.000 claims abstract description 22
- 230000009471 action Effects 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 25
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 239000003960 organic solvent Substances 0.000 claims description 20
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 11
- 239000003599 detergent Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 230000020477 pH reduction Effects 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 abstract description 16
- 238000003786 synthesis reaction Methods 0.000 abstract description 12
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 2
- 125000000524 functional group Chemical group 0.000 abstract description 2
- 239000000758 substrate Substances 0.000 abstract 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- BHTRKEVKTKCXOH-AYSJQVDDSA-N taurochenodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)C1C2C2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)CC1 BHTRKEVKTKCXOH-AYSJQVDDSA-N 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 229960002645 boric acid Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000010587 phase diagram Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
- 206010008609 Cholangitis sclerosing Diseases 0.000 description 1
- 208000004845 Cholecystolithiasis Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000013556 antirust agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003858 bile acid conjugate Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 201000000742 primary sclerosing cholangitis Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000010157 sclerosing cholangitis Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/12—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides
- B01J31/14—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides of aluminium or boron
- B01J31/146—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides of aluminium or boron of boron
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Steroid Compounds (AREA)
Abstract
The application relates to the technical field of medicine synthesis, and discloses a method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester, wherein ursodeoxycholic acid and taurine react under the action of boric acid ester to obtain tauroursodeoxycholic acid, and the molecular formula of the boric acid ester is B (OCH (CF) 3 ) 2 ) 3 . The method adopts the borate as the catalyst to synthesize the tauroursodeoxycholic acid, has high atom utilization rate in the method, obtains a product with a single structure, has wide application range to a substrate and has stronger tolerance to functional groups; solves the problems of high synthesis cost and difficult industrial application in the prior art.
Description
Technical Field
The application relates to the technical field of medicine synthesis, in particular to a method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester.
Background
Tauroursodeoxycholic acid is an active ingredient of bear bile, and is called TUDCA for short, and the chemical name is 3 alpha, 7 beta-dihydroxyl-cholanoyl-N-taurine. Tauroursodeoxycholic acid has the functions of spasmolysis, anticonvulsant, anti-inflammatory, cholelithiasis dissolving and the like, is mainly used for treating cholecystolithiasis, primary sclerosing cholangitis, primary biliary cirrhosis, chronic viral hepatitis C and the like clinically, and is focused by vast synthesizer workers.
Tauroursodeoxycholic acid is a conjugated bile acid formed by shrinking between carboxyl groups of ursodeoxycholic acid and taurine amino groups, and research on tauroursodeoxycholic acid has been very active in recent years, and chemical synthesis thereof has been attracting attention. At present, the chemical synthesis methods are mainly divided into three types: the mixed anhydride-phenolic ester method, the condensing agent method and the active thioester method. The condensing agent method refers to the method that amide is directly formed under the action of condensing agent. At present, when tauroursodeoxycholic acid is prepared by a condensing agent method, a reagent such as 4- (4, 6-dimethoxy-1, 3, 5-triazin-2-yl) -4-methylmorpholine salt (DMTMM) is frequently used as the condensing agent, and the reagent is high in price, unfavorable for controlling the cost and not suitable for industrial production.
Disclosure of Invention
The application aims to provide a method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester, which aims to solve the problems that the synthesis method has high cost and is not suitable for industrial production when the tauroursodeoxycholic acid is chemically synthesized in the prior art.
In order to achieve the above purpose, the application adopts the following technical scheme: ursodeoxycholic acid and taurine are reacted under the action of boric acid ester to obtain tauroursodeoxycholic acid, wherein the structural formula of the boric acid ester is B (OCH (CF) 3 ) 2 ) 3 。
The principle and the advantages of the scheme are as follows: in the technical proposal, ursodeoxycholic acid and taurine are used as raw materials, and the raw materials are mixed with boric acid ester (B (OCH (CF) 3 ) 2 ) 3 ) Under the condition of serving as a catalyst, the carboxyl of ursodeoxycholic acid and taurine amino are glycided to synthesize tauroursodeoxycholic acid. Wherein, the borate belongs to inorganic acid ester compounds, is a novel organic catalyst, and can be generally used as an efficient and environment-friendly lubricant, an antirust agent, a modified nano material rubber filler, a surfactant and the like. The technical scheme takes the catalyst as a catalyst for synthesis reaction, and has the advantages of high reaction rate and high reaction yield; b (OCH (CF) 3 ) 2 ) 3 The functional group has strong tolerance, and the hydroxyl in ursodeoxycholic acid can not influence the reaction; in B (OCH (CF) 3 ) 2 ) 3 Under the catalysis of the catalyst, a product with a single structure can be obtained, isomerization does not occur, and the post-treatment process is simple and easy to operate. In addition, no additional reagent is needed to assist in the reaction process, tauroursodeoxycholic acid is directly prepared by a one-pot method, the separation of intermediates is not needed, the process route is simplified, and in addition, the cost of the borate is relatively low, so that the method is suitable for industrialized mass production.
Preferably, as a modification, ursodeoxycholic acid is dissolved by an organic solvent before the reaction, and the addition ratio of ursodeoxycholic acid to the organic solvent is 1g: 2-10 ml.
In the technical scheme, the adding proportion range of the ursodeoxycholic acid and the organic solvent can ensure the effective dissolution of the ursodeoxycholic acid, and meanwhile, the waste caused by excessive organic solvent is avoided.
Preferably, as a modification, the organic solvent is one or more of dichloromethane, acetonitrile, methanol, ethanol, tetrahydrofuran, and N, N-dimethylformamide.
In the technical scheme, the adding type of the organic solvent is optimized, and the organic solvent can ensure the dissolution of ursodeoxycholic acid and is beneficial to the implementation of the later amidation reaction.
Preferably, as a modification, the organic solvent is a mixture of acetonitrile and tetrahydrofuran, and the volume ratio of acetonitrile to tetrahydrofuran is 5:1.
In the technical scheme, through optimizing an organic solvent, experiments prove that acetonitrile: under the condition of tetrahydrofuran=5:1, ursodeoxycholic acid can be fully dissolved, and the yield of tauroursodeoxycholic acid can be ensured to be about 90 percent by combining the optimization of the proportion of reaction raw materials and the reaction conditions.
Preferably, as a modification, in S2, the molar ratio of ursodeoxycholic acid, taurine and boric acid ester is 1:1-3:1-5.
In the technical scheme, the catalyst addition amount is optimized, so that the waste of resources can be avoided on the basis of ensuring sufficient catalysis, and the proportion is the optimal proportion range verified by the test.
Preferably, as a modification, in S2, the molar ratio of ursodeoxycholic acid, taurine and boric acid ester is 1:1-2:1-3.
In the technical scheme, in the synthesis process of tauroursodeoxycholic acid, the catalyst is too small to cause insufficient reaction, and the catalyst is excessive to cause side reaction to increase, so that the yield of tauroursodeoxycholic acid is reduced, and the waste of resources can be avoided on the basis of ensuring sufficient catalysis by optimizing the addition amount of the catalyst, so that the ratio is the optimal ratio range verified by experiments.
Preferably, as a modification, the reaction condition of ursodeoxycholic acid and taurine is that the temperature is raised to 20-80 ℃ for reaction for 6-10 h.
In the technical scheme, ursodeoxycholic acid and taurine react under the reaction conditions, so that the yield of the tauroursodeoxycholic acid can be ensured, and the tauroursodeoxycholic acid can completely react after 6-10 hours.
Preferably, as a modification, the tauroursodeoxycholic acid is obtained and then subjected to a purification treatment including extraction, washing, acidification, filtration and concentration.
In the technical scheme, after the tauroursodeoxycholic acid is preliminarily prepared through condensation reaction, impurities in the product can be effectively removed through operations such as extraction, washing, acidification, filtration, concentration and the like, the purity of the product is improved, and the pure tauroursodeoxycholic acid product is obtained.
Preferably, as a modification, in the extraction step, the extractant is methylene dichloride, and the addition ratio of tauroursodeoxycholic acid to the extractant is 1g: 3-10 ml, stirring for 10-30 min during extraction, and standing for 20-40 min.
In the technical scheme, when the adding proportion of the extractant is determined, crude tauroursodeoxycholic acid prepared by the reaction of ursodeoxycholic acid and taurine is taken as a reference, the extraction conditions are the optimal extraction conditions verified by experiments, and the tauroursodeoxycholic acid can be effectively purified by using dichloromethane.
Preferably, as a modification, in the washing step, the detergent is saturated sodium carbonate solution, and the addition ratio of tauroursodeoxycholic acid to the detergent is 1g: 4-6 ml, stirring for 10-30 min during washing, and standing for 20-40 min.
In the technical scheme, when the adding proportion of the detergent is determined, the crude tauroursodeoxycholic acid prepared by the reaction of ursodeoxycholic acid and taurine is taken as a reference, the washing condition is the optimal extraction condition verified by a test, and saturated sodium carbonate can be used for effectively extracting and purifying tauroursodeoxycholic acid.
Drawings
FIG. 1 is a sample liquid phase diagram of example 14.
FIG. 2 is a liquid phase diagram of the standard of example 14.
Detailed Description
The following is a further detailed description of the embodiments:
example 1
Ursodeoxycholic acid (cas: 128-13-2), taurine (cas: 07-35-7) and tauroursodeoxycholic acid (cas: 14605-22-2) are respectively shown in the formulas (I) - (III), and the molecular formula of the boric acid ester is as follows: b (OCH (CF) 3 ) 2 ) 3 The synthesis process of tauroursodeoxycholic acid in this example is shown in formula (IV).
The method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester comprises the following steps:
s1: 1mol of ursodeoxycholic acid is added into an organic solvent, and the organic solvent is placed on a magnetic stirrer and stirred uniformly at a rotating speed of 180rpm, wherein the organic solvent in the embodiment is methylene dichloride, and the addition ratio of the ursodeoxycholic acid to the organic solvent is 1g:4ml;
s2: adding 1mol of taurine and 1.5mol of boric acid ester into the dissolved reaction system, and reacting for 6 hours in a heating reflux state after the addition is finished to obtain tauroursodeoxycholic acid;
s3: extracting, washing, acidifying, filtering and concentrating after the reaction is finished to obtain pure tauroursodeoxycholic acid; in the extraction step, the extractant is dichloromethane, and the addition ratio of the dichloromethane to the tauroursodeoxycholic acid is 1g:4ml, stirring for 20min during extraction, and standing for 30min; in the washing step, the detergent is saturated sodium carbonate solution, and the adding ratio of the saturated sodium carbonate solution to tauroursodeoxycholic acid is 1g:4ml, stirring for 20min during washing, and standing for 30min. The solid tauroursodeoxycholic acid (sample to be detected, short for sample) was collected, and the yield of tauroursodeoxycholic acid was calculated to be 10%.
Examples 1-17, comparative examples 1-9 the settings of the parameters in the synthesis method are shown in the following table, wherein the default ursodeoxycholic acid addition amount is 1mol, 1g in solvent amount: 4ml means that ursodeoxycholic acid was dissolved in 4ml of organic solvent at an addition ratio of 1g ursodeoxycholic acid to organic solvent, and three repeated experiments were performed for each treatment group, and the results are expressed as an average.
TABLE 1
Note that: in the above table, B (OCH (CF) 3 ) 2 ) 3 Represents a borate catalyst, DCM represents dichloromethane, CH 3 CN represents acetonitrile, CH 3 OH represents methanol, etOH represents ethanol, THF represents tetrahydrofuran, DMF represents N, N-dimethylformamide, TUDCA represents tauroursodeoxycholic acid.
As is clear from Table 1, examples 2 to 10, in which the types of the organic solvents were respectively adjusted, showed that the types of the solvents had a large effect on TUDCA yield on the premise of a constant solvent addition amount, in which DCM and CH 3 CN、CH 3 OH, etOH, THF and DMF are used as solvents independently, the TUDCA yield is obviously lower than that of the organic solvent compounded use, wherein CH 3 When CN and THF are mixed in the volume ratio of 5:1, the TUDCA yield after the post-synthesis reaction is optimal.
Examples 11 to 13 and comparative examples 1 to 2, in which the amount of taurine added was adjusted, showed that the addition of 1 to 2mol of taurine did not greatly affect the TUDCA yield when the amount of taurine added was excessive, but the progress of the synthesis reaction was affected when the amount of taurine added was insufficient, and the TUDCA yield was decreased accordingly.
The catalyst addition amounts of examples 14 to 17 and comparative examples 5 to 6 were adjusted, and the results show that the catalyst addition amount has a large influence on the TUDCA yield, and when the catalyst addition amount is too low, the synthesis reaction is affected, the reaction is insufficient, and the TUDCA yield is reduced; and excessive addition of the catalyst leads to high side reactions and also to a decrease in TUDCA yield.
Comparative example 3-comparative example 4 the type of catalyst was adjusted, and the TUDCA yield was significantly reduced, not more than 30% of the TUDCA yield of the present technical scheme, without changing other reaction conditions. Comparative example 7-comparative example 9 the reaction temperature was adjusted, and the results show that chemical synthesis of tauroursodeoxycholic acid was also possible at normal temperature and relatively low temperature, but the TUDCA yield was relatively low, and also possible at high temperature, but the TUDCA yield was also decreased.
And (3) structural verification of the compound:
the condition of the synthesized product (sample) was detected using liquid chromatography, and tauroursodeoxycholic acid having a purity of 99% was used as a standard. Liquid chromatogram of the sample prepared in example 14 referring to fig. 1, the abscissa is time in units: in minutes, the liquid chromatogram of the standard substance is shown in fig. 2, and the retention time of tauroursodeoxycholic acid peaks is consistent in comparison between fig. 1 and fig. 2, which shows that tauroursodeoxycholic acid is successfully synthesized by the scheme. Further, the sample is identified by nuclear magnetic resonance detection to be tauroursodeoxycholic acid. In addition, according to the graph, the tauroursodeoxycholic acid prepared by the technical scheme has few impurity peaks and the product is relatively single.
The foregoing is merely exemplary of the present application, and specific technical solutions and/or features that are well known in the art have not been described in detail herein. It should be noted that, for those skilled in the art, several variations and modifications can be made without departing from the technical solution of the present application, and these should also be regarded as the protection scope of the present application, which does not affect the effect of the implementation of the present application and the practical applicability of the patent. The protection scope of the present application is subject to the content of the claims, and the description of the specific embodiments and the like in the specification can be used for explaining the content of the claims.
Claims (8)
1. The method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester is characterized by comprising the following steps: ursodeoxycholic acid and taurine are reacted under the action of boric acid ester to obtain tauroursodeoxycholic acid, wherein the molecular formula of the boric acid ester is B (OCH (CF) 3 ) 2 ) 3 The method comprises the steps of carrying out a first treatment on the surface of the Ursodeoxycholic acid is dissolved in organic solvent before reaction, wherein the organic solvent isAcetonitrile and tetrahydrofuran in the volume ratio of 5 to 1.
2. The method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester according to claim 1, wherein the method comprises the following steps: the addition ratio of ursodeoxycholic acid to organic solvent is 1g: 2-10 ml.
3. The method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester according to claim 2, wherein the method comprises the following steps: the mol ratio of ursodeoxycholic acid to taurine to boric acid ester is 1:1-3:1-5.
4. A method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester according to claim 3, wherein: the mol ratio of ursodeoxycholic acid to taurine to boric acid ester is 1:1-2:1-3.
5. The method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester according to claim 4, wherein the method comprises the following steps: the reaction condition of ursodeoxycholic acid and taurine is that the temperature is raised to 20-80 ℃ for reaction for 6-10 h.
6. The method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester according to claim 5, wherein the method comprises the following steps: after obtaining tauroursodeoxycholic acid, carrying out purification treatment, wherein the purification treatment comprises extraction, washing, acidification, filtration and concentration.
7. The method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester according to claim 6, wherein the method comprises the following steps: in the extraction step, the extractant is methylene dichloride, and the adding ratio of the tauroursodeoxycholic acid to the extractant is 1g: 3-10 ml, stirring for 10-30 min during extraction, and standing for 20-40 min.
8. The method for synthesizing tauroursodeoxycholic acid under the catalysis of boric acid ester according to claim 7, wherein the method comprises the following steps: in the washing step, the detergent is saturated sodium carbonate solution, and the adding ratio of the tauroursodeoxycholic acid to the detergent is 1g: 4-6 ml, stirring for 10-30 min during washing, and standing for 20-40 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011531308.0A CN112645998B (en) | 2020-12-22 | 2020-12-22 | Method for synthesizing tauroursodeoxycholic acid under catalysis of borate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011531308.0A CN112645998B (en) | 2020-12-22 | 2020-12-22 | Method for synthesizing tauroursodeoxycholic acid under catalysis of borate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112645998A CN112645998A (en) | 2021-04-13 |
| CN112645998B true CN112645998B (en) | 2023-08-18 |
Family
ID=75359208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011531308.0A Active CN112645998B (en) | 2020-12-22 | 2020-12-22 | Method for synthesizing tauroursodeoxycholic acid under catalysis of borate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112645998B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112588319A (en) * | 2020-12-22 | 2021-04-02 | 重庆极泽生物科技有限公司 | Application of silane and synthesis of tauroursodeoxycholic acid under catalysis of silane |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101307088A (en) * | 2008-07-08 | 2008-11-19 | 四川大学 | A kind of preparation method of cholic acid conjugate |
| CN103183716A (en) * | 2011-12-31 | 2013-07-03 | 山东天绿制药有限公司 | Preparation method of tauro ursodesoxy cholic acid |
| CN111825737A (en) * | 2019-04-16 | 2020-10-27 | 迪法玛弗朗西斯有限公司 | Purification of cholanic acid conjugates |
-
2020
- 2020-12-22 CN CN202011531308.0A patent/CN112645998B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101307088A (en) * | 2008-07-08 | 2008-11-19 | 四川大学 | A kind of preparation method of cholic acid conjugate |
| CN103183716A (en) * | 2011-12-31 | 2013-07-03 | 山东天绿制药有限公司 | Preparation method of tauro ursodesoxy cholic acid |
| CN111825737A (en) * | 2019-04-16 | 2020-10-27 | 迪法玛弗朗西斯有限公司 | Purification of cholanic acid conjugates |
Non-Patent Citations (1)
| Title |
|---|
| Borate esters: Simple catalysts for the sustainable synthesis of complex amides;Marco T. Sabatini 等;《SCIENCE ADVANCES》;20170922;第3卷;第1-8页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112645998A (en) | 2021-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114539343B (en) | Preparation method of glycocholic acid | |
| CN1583776A (en) | Preparing method for cytarabine | |
| CN112645998B (en) | Method for synthesizing tauroursodeoxycholic acid under catalysis of borate | |
| WO2023280313A1 (en) | Method for purifying ursodeoxycholic acid | |
| CN111777628B (en) | Catalytic wet oxidation catalyst for treating glyphosate wastewater, and synthesis method and application thereof | |
| CN101973932A (en) | Preparation method of bisacodyl | |
| CN106883227B (en) | The method for preparing ergometrine by ergot fermentation waste | |
| CN1086207A (en) | The preparation method of keto-amine and derivative thereof | |
| CN111253272B (en) | Method for preparing benzamide compound | |
| CN116120226A (en) | A kind of synthetic technique of 5-hydroxymethyl nicotinonitrile | |
| CN115322239B (en) | Method for recovering diketone from mandipropamid carbon loss ester mother liquor | |
| CN111019980A (en) | Efficient biosynthesis method of mono-p-nitrobenzyl malonate | |
| CN114539081B (en) | Method for separating and purifying glycine by utilizing N, N-dibutyl ethanolamine | |
| CN119707902B (en) | A kind of preparation method of daphnetoside | |
| CN112898283B (en) | Synthetic method of tetrahydrothiophene derivatives | |
| CN110590602A (en) | Resolution refining method of racemic citalopram diol | |
| CN115703750B (en) | Extraction and purification method of 1-amino-4-methylpiperazine | |
| CN112940062B (en) | Preparation method of 16-dehydroprogesterone | |
| CN116023280B (en) | Synthesis method of 2-amino-4-nitrophenol | |
| CN110003180A (en) | Pyrroles-pyridine-pyrrole class compound post-processing purification process | |
| CN115945215B (en) | Sodium lignin sulfonate quaternary ammonium salt supported phosphotungstic acid catalyst, preparation method thereof and application of oxidized oleic acid in preparation of azelaic acid | |
| CN112588319A (en) | Application of silane and synthesis of tauroursodeoxycholic acid under catalysis of silane | |
| CN110240551B (en) | Preparation method of Fmoc-beta-Ala-Gly-OH | |
| CN102391140A (en) | Preparation method of N-(2- indanyl) amino acid alkyl ester | |
| CN115925534A (en) | Preparation method of high-purity tropic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |